Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|3|3|257-273

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.3, Iss.3, 2002-06, pp. : 257-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional interactions between P-glycoprotein and CYP3A in drug metabolism

By Christians Uwe   Schmitz Volker   Haschke Manuel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 641-654

Informa Healthcare

Access to resources Recommend Favorite

The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions

By DuBuske Lawrence M.  

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 789-801

Adis International

Access to resources Recommend Favorite

P-Glycoprotein System As a Determinant of Drug Interactions: The Case of Digoxin–verapamil

By Verschraagen M.   Koks C.H.W.   Schellens J.H.M.   Beijnen J.H.  

Pharmacological Research, Vol. 40, Iss. 4, 1999-10 ,pp. : 301-306

Academic Press

Access to resources Recommend Favorite

Role of P-Glycoprotein Inhibition for Drug Interactions: Evidence from In Vitro and Pharmacoepidemiological Studies

By Eberl Sonja   Renner Bertold  

Clinical Pharmacokinetics, Vol. 46, Iss. 12, 2007-01 ,pp. : 1039-1049

Adis International

Access to resources Recommend Favorite

Predicting Drug-Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 762-777

Bentham Science Publishers

Access to resources Recommend Favorite